|
| All | OV | Without OV | p |
| Male | 79 | 74 (93.7%) | 5 (6.3%) | 0.37 |
| Female | 22 | 19 (86.4%) | 3 (13.6%) | 0.37 |
| Age < 50 years | 58 | 52 (89.7%) | 6 (10.3%) | 0.46 |
| Age ≥ 50 years | 43 | 41 (95.3%) | 2 (4.7%) | 0.46 |
| Clinical findings: |
|
|
|
|
| Ascites | 90 | 83 (92.2%) | 7 (7.8%) | 1.00 |
| Jaundice | 35 | 31 (88.6%) | 4 (11.4%) | 0.44 |
| Large spleen | 21 | 21 (100%) | 0 (0%) | 0.12 |
| Large liver | 28 | 26 (92.9%) | 2 (7.1%) | 1.00 |
| Collateral venous circulation | 14 | 14 (100%) | 0 (0%) | 0.59 |
| Haematemesis-Melaena | 11 | 11 (100%) | 0 (0%) | 0.59 |
| Hepatic encephalopathy | 2 | 1 (50%) | 1 (50%) | 0.15 |
| Etiology of cirrhosis: |
|
|
|
|
| HBV | 65 | 59 (90.8%) | 6 (9.2%) | 0.67 |
| HCV | 21 | 18 (85.7%) | 3 (14.3%) | 0.24 |
| alcohol | 6 | 6 (100%) | 0 (0%) | 1.00 |
| Complications: |
|
|
|
|
| Haematemesis-Melaena | 25 | 25 (100%) | 0 (0%) | 0.19 |
| hepatocellular carcinoma | 22 | 21 (95.5%) | 1 (4.5%) | 0.68 |
| Liquid ascite infection | 14 | 13 (92.9%) | 1 (7.1%) | 1.00 |
| Hepatic encephalopathy | 13 | 12 (92.3%) | 1 (7.7%) | 1.00 |
| Hepatorenal syndrome | 2 | 2 (100%) | 0 (0%) | 1.00 |